TAC1 Human

Tachykinin-1 Human Recombinant
Cat. No.
BT10296
Source
Escherichia Coli.
Synonyms

Protachykinin-1, Protachykinin 1, 4930528L02Rik, NK-1, NK1, Nka, Nkna, Neurokinin 2, Neurokinin A, Neurokinin alpha, Neuromedin L, Neuropeptide K, Substance P, Tachykinin precursor 1.

Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TAC1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 135 amino acids (20-129 a.a) and having a molecular mass of 15.6kDa.
TAC1 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Tachykinin-1 (TAC1) is a member of the tachykinin family of peptide hormones. These peptides share a common C-terminal sequence (phe-X-gly-leu-met-NH2) responsible for their similar biological activities. However, their unique N-terminal sequences allow them to interact with specific receptors. TAC1 is believed to function as a neurotransmitter, interacting with nerve receptors and smooth muscle cells to induce behavioral responses, vasodilation, and secretion.
Description
Recombinant human TAC1, expressed in E. coli, is a single, non-glycosylated polypeptide chain comprising 135 amino acids (residues 20-129). It has a molecular weight of 15.6 kDa. The protein is fused to a 25 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
The product is a sterile, colorless solution.
Formulation
The TAC1 protein is supplied as a 1 mg/ml solution in 20 mM Tris-HCl buffer (pH 8.0) containing 10% glycerol and 2M Urea.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to store the protein at -20°C. To further enhance stability during long-term storage, adding a carrier protein (0.1% HSA or BSA) is advised. Avoid repeated freeze-thaw cycles.
Purity
The purity of the TAC1 protein is greater than 95% as determined by SDS-PAGE analysis.
Synonyms

Protachykinin-1, Protachykinin 1, 4930528L02Rik, NK-1, NK1, Nka, Nkna, Neurokinin 2, Neurokinin A, Neurokinin alpha, Neuromedin L, Neuropeptide K, Substance P, Tachykinin precursor 1.

Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMEEIGA NDDLNYWSDW YDSDQIKEEL PEPFEHLLQR IARRPKPQQF FGLMGKRDAD SSIEKQVALL KALYGHGQIS HKRHKTDSFV GLMGKRALNS VAYERSAMQN YERRR.

Product Science Overview

Introduction

Tachykinin-1, also known as Substance P, is a member of the tachykinin family of neuropeptides. These peptides are characterized by a common C-terminal sequence, which is essential for their biological activity. Tachykinin-1 plays a crucial role in various physiological processes, including pain transmission, inflammation, and smooth muscle contraction.

Structure and Synthesis

Tachykinin-1 is an undecapeptide, meaning it consists of 11 amino acids. The amino acid sequence of Tachykinin-1 is Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 . This sequence is highly conserved across different species, indicating its importance in biological functions.

The synthesis of recombinant Tachykinin-1 involves the use of genetic engineering techniques. The gene encoding Tachykinin-1 is inserted into an expression vector, which is then introduced into a host cell, such as E. coli or yeast. The host cells produce the peptide, which is subsequently purified for research or therapeutic use.

Receptors and Mechanism of Action

Tachykinin-1 exerts its effects by binding to the neurokinin-1 receptor (NK1R), a G protein-coupled receptor found in both the central and peripheral nervous systems . The binding of Tachykinin-1 to NK1R triggers a cascade of intracellular events, leading to the activation of various signaling pathways. These pathways are involved in the transmission of pain signals, regulation of inflammatory responses, and modulation of smooth muscle activity .

Biological Functions
  1. Pain Transmission: Tachykinin-1 is a key mediator in the transmission of pain signals. It is released from sensory neurons in response to noxious stimuli and binds to NK1R on postsynaptic neurons, leading to the perception of pain .
  2. Inflammation: Tachykinin-1 plays a significant role in the inflammatory response. It promotes the release of pro-inflammatory cytokines and chemokines, leading to the recruitment of immune cells to the site of inflammation .
  3. Smooth Muscle Contraction: Tachykinin-1 induces the contraction of smooth muscles in various tissues, including the gastrointestinal tract, respiratory system, and blood vessels. This action is mediated through the activation of NK1R on smooth muscle cells .
Clinical Applications

Recombinant Tachykinin-1 has been extensively studied for its potential therapeutic applications. It is used in research to understand the mechanisms underlying pain and inflammation. Additionally, NK1R antagonists, which block the binding of Tachykinin-1 to its receptor, are being developed as potential treatments for conditions such as chronic pain, depression, and chemotherapy-induced nausea and vomiting .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.